Journal article

Epidemiology and risks for infection following cytoreductive surgery and hyperthermic intra-peritoneal chemotherapy

OC Smibert, MA Slavin, B Teh, AG Heriot, J Penno, H Ismail, KA Thursky, LJ Worth

Supportive Care in Cancer | SPRINGER | Published : 2019

Abstract

BACKGROUND: CRS-HIPEC is associated with improved cancer survival but an increased risk of infection. METHODS: Consecutive patients undergoing CRS-HIPEC between January 2016 and May 2018 were retrospectively reviewed. Malignancy type, comorbidities, perioperative risk factors and infectious complications were captured, using standardised definitions. Association between risk factors and infection outcomes was evaluated by logistic regression modelling. RESULTS: One-hundred patients underwent CRS-HIPEC, predominantly for colorectal cancer and pseudomyxoma peritonei. Overall, 43 (43.0%) experienced an infectious complication, including infections at surgical site (27), respiratory tract (9), u..

View full abstract